BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 8033426)

  • 1. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.
    Ma Y; Peakman M; Lobo-Yeo A; Wen L; Lenzi M; Gäken J; Farzaneh F; Mieli-Vergani G; Bianchi FB; Vergani D
    Clin Exp Immunol; 1994 Jul; 97(1):94-9. PubMed ID: 8033426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.
    Muratori L; Lenzi M; Ma Y; Cataleta M; Mieli-Vergani G; Vergani D; Bianchi FB
    Gut; 1995 Sep; 37(3):406-12. PubMed ID: 7590439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection.
    Ma Y; Gregorio G; Gäken J; Muratori L; Bianchi FB; Mieli-Vergani G; Vergani D
    J Hepatol; 1997 Jun; 26(6):1396-402. PubMed ID: 9210629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-LKM-1 antibodies determined by use of recombinant P450 2D6 in ELISA and western blot and their association with anti-HCV and HCV-RNA.
    Seelig R; Renz M; Bünger G; Schröter H; Seelig HP
    Clin Exp Immunol; 1993 Jun; 92(3):373-80. PubMed ID: 8390333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C.
    Miyakawa H; Kitazawa E; Kikuchi K; Fujikawa H; Kawaguchi N; Abe K; Matsushita M; Matsushima H; Igarashi T; Hankins RW; Kako M
    Autoimmunity; 2000; 33(1):23-32. PubMed ID: 11204250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon therapy in LKM-1 positive patients with chronic hepatitis C: follow-up by a quantitative radioligand assay for CYP2D6 antibody detection.
    Duclos-Vallée JC; Nishioka M; Hosomi N; Arima K; Leclercq A; Bach JF; Yamamoto AM
    J Hepatol; 1998 Jun; 28(6):965-70. PubMed ID: 9672171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.
    Sugimura T; Obermayer-Straub P; Kayser A; Braun S; Loges S; Alex B; Lüttig B; Johnson EF; Manns MP; Strassburg CP
    Autoimmunity; 2002 Dec; 35(8):501-13. PubMed ID: 12765476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.
    Manns MP; Johnson EF; Griffin KJ; Tan EM; Sullivan KF
    J Clin Invest; 1989 Mar; 83(3):1066-72. PubMed ID: 2466049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece.
    Dalekos GN; Makri E; Loges S; Obermayer-Straub P; Zachou K; Tsikrikas T; Schmidt E; Papadamou G; Manns MP
    Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):35-42. PubMed ID: 11782573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.
    Klein R; Zanger UM; Berg T; Hopf U; Berg PA
    Clin Exp Immunol; 1999 Nov; 118(2):290-7. PubMed ID: 10540193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type-2 (AIH-2) and chronic hepatitis C virus (HCV) infection: a sensitive and quantitative radioligand assay.
    Yamamoto AM; Johanet C; Duclos-Vallee JC; Bustarret FA; Alvarez F; Homberg JC; Bach JF
    Clin Exp Immunol; 1997 Jun; 108(3):396-400. PubMed ID: 9182882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of anti-LKM-1(anti-CYP2D6) by an enzyme-linked immunosorbent assay in adult patients with chronic liver diseases.
    Miyakawa H; Kikazawa E; Abe K; Kikuchi K; Fujikawa H; Matsushita M; Kawaguchi N; Morizane T; Ohya K; Kako M
    Autoimmunity; 1999; 30(2):107-14. PubMed ID: 10435724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment.
    Dalekos GN; Wedemeyer H; Obermayer-Straub P; Kayser A; Barut A; Frank H; Manns MP
    J Hepatol; 1999 Mar; 30(3):366-75. PubMed ID: 10190716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-GOR and hepatitis C virus in autoimmune liver diseases.
    Michel G; Ritter A; Gerken G; Meyer zum Büschenfelde KH; Decker R; Manns MP
    Lancet; 1992 Feb; 339(8788):267-9. PubMed ID: 1346282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.
    Kerkar N; Choudhuri K; Ma Y; Mahmoud A; Bogdanos DP; Muratori L; Bianchi F; Williams R; Mieli-Vergani G; Vergani D
    J Immunol; 2003 Feb; 170(3):1481-9. PubMed ID: 12538711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sera of children with hepatitis C infection and anti-liver-kidney microsome-1 antibodies recognize different CYP2D6 epitopes than adults with LKM+/HCV+ sera.
    Herzog D; Yamamoto AM; Jara P; Maggiore G; Sarles J; Alvarez F
    J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):551-5. PubMed ID: 10554122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational epitopes on CYP2D6 are recognized by liver/kidney microsomal antibodies.
    Duclos-Vallée JC; Hajoui O; Yamamoto AM; Jacz-Aigrain E; Alvarez F
    Gastroenterology; 1995 Feb; 108(2):470-6. PubMed ID: 7530671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection.
    Durazzo M; Philipp T; Van Pelt FN; Lüttig B; Borghesio E; Michel G; Schmidt E; Loges S; Rizzetto M; Manns MP
    Gastroenterology; 1995 Feb; 108(2):455-62. PubMed ID: 7835588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.